Switch to: References

Add citations

You must login to add citations.
  1. Chronic disease as risk multiplier for disadvantage.Francisca Stutzin Donoso - 2018 - Journal of Medical Ethics 44 (6):371-375.
    This paper starts by establishing a prima facie case that disadvantaged groups or individuals are more likely to get a chronic disease and are in a disadvantaged position to adhere to chronic treatment despite access through Universal Health Coverage. However, the main aim of this paper is to explore the normative implications of this claim by examining two different but intertwined argumentative lines that might contribute to a better understanding of the ethical challenges faced by chronic disease health policy. The (...)
    Direct download (6 more)  
     
    Export citation  
     
    Bookmark   4 citations  
  • Focus on infectious disease.Michael Selgelid - 2005 - Poiesis and Praxis 3 (4):227-228.
  • From the guest editors.Michael J. Selgelid & Margaret P. Battin - 2005 - Bioethics 19 (4):iii–vii.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  • Ethics and drug resistance.Michael J. Selgelid - 2007 - Bioethics 21 (4):218–229.
    ABSTRACT This paper reviews the dynamics behind, and ethical issues associated with, the phenomenon of drug resistance. Drug resistance is an important ethical issue partly because of the severe consequences likely to result from the increase in drug resistant pathogens if more is not done to control them. Drug resistance is also an ethical issue because, rather than being a mere quirk of nature, the problem is largely a product of drug distribution. Drug resistance results from the over‐consumption of antibiotics (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   16 citations  
  • Are Contact Precautions ethically justifiable in contemporary hospital care?Joanna Harris, Kenneth Walsh & Susan Dodds - 2019 - Nursing Ethics 26 (2):611-624.
    Direct download  
     
    Export citation  
     
    Bookmark   1 citation  
  • How infectious diseases got left out – and what this omission might have meant for bioethics.Leslie P. Francis, Margaret P. Battin, Jay A. Jacobson, Charles B. Smith & And Jeffrey Botkin - 2005 - Bioethics 19 (4):307–322.
    ABSTRACT In this article, we first document the virtually complete absence of infectious disease examples and concerns at the time bioethics emerged as a field. We then argue that this oversight was not benign by considering two central issues in the field, informed consent and distributive justice, and showing how they might have been framed differently had infectiousness been at the forefront of concern. The solution to this omission might be to apply standard approaches in liberal bioethics, such as autonomy (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   18 citations  
  • How Infectious Diseases Got Left Out – and What This Omission Might Have Meant for Bioethics.Leslie P. Francis, Margaret P. Battin, Jay A. Jacobson, Charles B. Smith & Jeffrey Botkin - 2005 - Bioethics 19 (4):307-322.
    ABSTRACT In this article, we first document the virtually complete absence of infectious disease examples and concerns at the time bioethics emerged as a field. We then argue that this oversight was not benign by considering two central issues in the field, informed consent and distributive justice, and showing how they might have been framed differently had infectiousness been at the forefront of concern. The solution to this omission might be to apply standard approaches in liberal bioethics, such as autonomy (...)
    Direct download  
     
    Export citation  
     
    Bookmark   22 citations